Extracorporeal membrane oxygenation in COVID-19 compared to other etiologies of acute respiratory failure : A single-center experience
Copyright © 2022. Published by Elsevier Inc..
BACKGROUND: The COVID-19 pandemic has led to a boom in the use of V-V ECMO for ARDS secondary to COVID. Comparisons of outcomes of ECMO for COVID to ECMO for influenza have emerged. Very few comparisons of ECMO for COVID to ECMO for ARDS of all etiologies are available.
OBJECTIVES: To compare clinically important outcome measures in recipients of ECMO for COVID to those observed in recipients of ECMO for ARDS of other etiologies.
METHODS: V-V ECMO recipients between March 2020 and March 2022 consisted exclusively of COVID patients and formed the COVID ECMO group. All patients who underwent V-V ECMO for ARDS between January 2014 and March 2020 were eligible for analysis as the non-COVID ECMO comparator group. The primary outcome was survival to hospital discharge. Secondary outcomes included ECMO decannulation, ECMO duration >30 days, and serious complications.
RESULTS: Thirty-six patients comprised the COVID ECMO group and were compared to 18 non-COVID ECMO patients. Survival to hospital discharge was not significantly different between the two groups (33% in COVID vs. 50% in non-COVID; p = 0.255) nor was there a significant difference in the rate of non-palliative ECMO decannulation. The proportion of patients connected to ECMO for >30 days was significantly higher in the COVID ECMO group: 69% vs. 17%; p = 0.001. There was no significant difference in serious complications.
CONCLUSION: This study could not identify a statistically significant difference in hospital survival and rate of successful ECMO decannulation between COVID ECMO and non-COVID ECMO patients. Prolonged ECMO may be more common in COVID. Complications were not significantly different.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Heart & lung : the journal of critical care - 57(2023) vom: 05. Jan., Seite 243-249 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yaqoob, Hamid [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute respiratory distress syndrome |
|---|
| Anmerkungen: |
Date Completed 07.12.2022 Date Revised 27.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.hrtlng.2022.10.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347891314 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347891314 | ||
| 003 | DE-627 | ||
| 005 | 20231226034916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.hrtlng.2022.10.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM347891314 | ||
| 035 | |a (NLM)36274533 | ||
| 035 | |a (PII)S0147-9563(22)00237-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yaqoob, Hamid |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracorporeal membrane oxygenation in COVID-19 compared to other etiologies of acute respiratory failure |b A single-center experience |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.12.2022 | ||
| 500 | |a Date Revised 27.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022. Published by Elsevier Inc. | ||
| 520 | |a BACKGROUND: The COVID-19 pandemic has led to a boom in the use of V-V ECMO for ARDS secondary to COVID. Comparisons of outcomes of ECMO for COVID to ECMO for influenza have emerged. Very few comparisons of ECMO for COVID to ECMO for ARDS of all etiologies are available | ||
| 520 | |a OBJECTIVES: To compare clinically important outcome measures in recipients of ECMO for COVID to those observed in recipients of ECMO for ARDS of other etiologies | ||
| 520 | |a METHODS: V-V ECMO recipients between March 2020 and March 2022 consisted exclusively of COVID patients and formed the COVID ECMO group. All patients who underwent V-V ECMO for ARDS between January 2014 and March 2020 were eligible for analysis as the non-COVID ECMO comparator group. The primary outcome was survival to hospital discharge. Secondary outcomes included ECMO decannulation, ECMO duration >30 days, and serious complications | ||
| 520 | |a RESULTS: Thirty-six patients comprised the COVID ECMO group and were compared to 18 non-COVID ECMO patients. Survival to hospital discharge was not significantly different between the two groups (33% in COVID vs. 50% in non-COVID; p = 0.255) nor was there a significant difference in the rate of non-palliative ECMO decannulation. The proportion of patients connected to ECMO for >30 days was significantly higher in the COVID ECMO group: 69% vs. 17%; p = 0.001. There was no significant difference in serious complications | ||
| 520 | |a CONCLUSION: This study could not identify a statistically significant difference in hospital survival and rate of successful ECMO decannulation between COVID ECMO and non-COVID ECMO patients. Prolonged ECMO may be more common in COVID. Complications were not significantly different | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acute respiratory distress syndrome | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Extracorporeal membrane oxygenation | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Greenberg, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Lawrence |e verfasserin |4 aut | |
| 700 | 1 | |a Henson, Theresa |e verfasserin |4 aut | |
| 700 | 1 | |a Pitaktong, Areen |e verfasserin |4 aut | |
| 700 | 1 | |a Peneyra, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Spencer, Philip J |e verfasserin |4 aut | |
| 700 | 1 | |a Malekan, Ramin |e verfasserin |4 aut | |
| 700 | 1 | |a Goldberg, Joshua B |e verfasserin |4 aut | |
| 700 | 1 | |a Kai, Masashi |e verfasserin |4 aut | |
| 700 | 1 | |a Ohira, Suguru |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zhen |e verfasserin |4 aut | |
| 700 | 1 | |a Murad, M Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Chandy, Dipak |e verfasserin |4 aut | |
| 700 | 1 | |a Epelbaum, Oleg |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heart & lung : the journal of critical care |d 1973 |g 57(2023) vom: 05. Jan., Seite 243-249 |w (DE-627)NLM00000460X |x 1527-3288 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2023 |g day:05 |g month:01 |g pages:243-249 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.hrtlng.2022.10.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2023 |b 05 |c 01 |h 243-249 | ||